References
- 1Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017; 317(2):165–82. DOI: 10.1001/jama.2016.19043
- 2Zheng J, Wang J, Zhang Y, Xia J, Guo H, Hu H, et al. The global burden of diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019. Front Public Health. 2022; 10:891929. DOI: 10.3389/fpubh.2022.891929
- 3Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387(10022):957–67. DOI: 10.1016/S0140-6736(15)01225-8
- 4Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013; 2013(1):CD004816. DOI: 10.1002/14651858.CD004816.pub5
- 5Ference BA, Braunwald E, Catapano AL. The LDL cumulative exposure hypothesis: Evidence and practical applications. Nat Rev Cardiol. 2024; 21:701–716. DOI: 10.1038/s41569-024-01039-5
- 6Zhu JZ, Manne-Goehler J, Agarwal A, Bahendeka SK, Damasceno A, Marcus ME, et al. Medication use for cardiovascular disease prevention in 40 lowLow- and middle-income countries. J Am Coll Cardiol. 2023; 81(6):620–2. DOI: 10.1016/j.jacc.2022.12.003
- 7Marcus ME, Manne-Goehler J, Theilmann M, Farzadfar F, Moghaddam SS, Keykhaei M, et al. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data. Lancet Glob Health. 2022; 10(3):e369–e79. DOI: 10.1016/S2214-109X(21)00551-9
- 8World Health Organization.
HEARTS technical package . Geneva: World Health Organization; 2018 Available from:https://www.knowledge-action-portal.com/en/content/hearts-technical-package . - 9Moran AE, Gupta R, Global Hearts Initiative Collaborators. Implementation of Global Hearts hypertension control programs in 32 low- and middle-income countries: JACC International. J Am Coll Cardiol. 2023; 82(19):1868–84. DOI: 10.1016/j.jacc.2023.08.043
- 10Abrar A, Hu X, Akhtar J, Jubayer S, Sayem MNN, Sultana S, et al. Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: A quasi-experimental trial. Heart. 2024; 110(17):1090–8. DOI: 10.1136/heartjnl-2024-324253